FDA says updated COVID-19 Omicron boosters won’t require new clinical trials

A Food and Drug Administration official said COVID-19 vaccine makers won’t need to carry out fresh clinical trials to receive approval for booster shots they’re updating for newer Omicron variants. Dr. Peter Marks, who runs the FDA’s Center for Biologics Evaluation and Research, told Reuters the agency will use data from trials for vaccines that target BA.1 — the Omicron variant that caused a huge surge in infections last winter — as well as manufacturing data to assess the vaccines. Safety data and preclinical data from animal studies may also be used. 

This week, the FDA asked vaccine manufacturers to modify booster shots to target the Omicron BA.4 and

→ Continue reading at Engadget

Similar Articles


Most Popular

Disney’s Kareem Daniel, Tracee Ellis Ross and Blumhouse’s Jason Blum and Abhijay Prakash Join Variety’s Entertainment and Technology Summit

Variety is pleased to announce the in-person return of its annual Entertainment and Technology Summit, presented by City National Bank in West Hollywood on...

How ‘Curb Your Enthusiasm’ Continues to Soar After 11 Seasons

After 11 seasons and more than two decades on HBO, Emmy voters are still finding “Curb Your Enthusiasm” to be, in Larry David parlance,...

Cubs Beat Reds at MLB’s Field of Dreams Game

The Chicago Cubs beat the Cincinnati Reds, 4-2, on Thursday, but that was hardly the point.Major League Baseball had once again found its way...